Related Topics News -

     
 Title only   |   Print 
     
中生製藥周三回購800萬股 涉4,132萬元

2026-10-14T  
中國生物製藥斥約3,956萬元回購740萬股

2026-10-13T  
中生製藥:TQC3721吸入混懸液PDE3/4抑制劑III期臨床完成受試者入組

2026-10-08T  
《大行》里昂:中國醫療保健授權交易動能增強 維持對行業正面看法

2026-10-06T  
《大行》美銀證券:中國醫藥/生物科技三項合作強化板塊動能 上調恆瑞及中生製藥目標價

2026-10-02T  
《大行》花旗:中生製藥與STADA達成生物類似藥戰略合作帶來驚喜

2026-09-29T  
中生製藥與STADA達成生物類似藥戰略合作 里程碑付款高達4.7億元

2026-09-28T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.